Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -42.07% is 32% below its 5-year average of -31.81%, around the middle of its 5-year range (-62.18%–-16.55%).
As of the fiscal period ended Tuesday, June 30, 2026. 4.97% above its 12-month average of -44.26%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -42.07%.
RETURN ON EQUITY (ROE)
-42.07%
RETURN ON EQUITY (ROE) AVG TTM
-44.26%
RETURN ON EQUITY (ROE) AVG 3Y
-34.42%
RETURN ON EQUITY (ROE) AVG 5Y
-31.81%
RETURN ON EQUITY (ROE) AVG 10Y
-37.25%
RETURN ON EQUITY (ROE) AVG 15Y
-38.64%
RETURN ON EQUITY (ROE) AVG 20Y
-38.89%
CURRENT VS TTM AVG
+4.97%
CURRENT VS 3Y AVG
-22.21%
CURRENT VS 5Y AVG
-32.25%
CURRENT VS 10Y AVG
-12.92%
CURRENT VS 15Y AVG
-8.86%
CURRENT VS 20Y AVG
-8.17%
SECTOR MEDIAN · HEALTHCARE
-38.53%
median of 484 covered companies
CURRENT VS SECTOR MEDIAN
-9.18%
vs the sector median at left
Celldex Therapeutics, Inc.
Market Cap
$2.12B
Return on Equity (ROE)
-42.07%
TTM Avg
-44.26%
3Y Avg
-34.42%
5Y Avg
-31.81%
Market Cap
$2.03B
Return on Equity (ROE)
-8.14%
TTM Avg
-6.28%
3Y Avg
-6.47%
5Y Avg
-2.03%
Market Cap
$2.12B
Return on Equity (ROE)
9.17%
TTM Avg
8.21%
3Y Avg
8.13%
5Y Avg
7.80%
Market Cap
$2.17B
Return on Equity (ROE)
-16.25%
TTM Avg
-99.56%
3Y Avg
-48.75%
5Y Avg
-32.00%
Market Cap
$2.04B
Return on Equity (ROE)
N/A
TTM Avg
-101.38%
3Y Avg
-17.29%
5Y Avg
175.33%
Market Cap
$2.02B
Return on Equity (ROE)
16.36%
TTM Avg
13.19%
3Y Avg
3.41%
5Y Avg
-4.94%
Market Cap
$2.02B
Return on Equity (ROE)
-63.45%
TTM Avg
-58.44%
3Y Avg
-22.42%
5Y Avg
15.04%
Market Cap
$2.01B
Return on Equity (ROE)
51.09%
TTM Avg
25.46%
3Y Avg
0.90%
5Y Avg
-9.89%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | $2.12B | -42.07% | -44.26% | -34.42% | -31.81% |
| Azenta, Inc. (AZTA)vs › | $2.03B | -8.14% | -6.28% | -6.47% | -2.03% |
| Addus HomeCare Corporation (ADUS)vs › | $2.12B | 9.17% | 8.21% | 8.13% | 7.80% |
| Fortrea Holdings Inc. (FTRE)vs › | $2.17B | -16.25% | -99.56% | -48.75% | -32.00% |
| Alvotech (ALVO)vs › | $2.07B | N/A | 23.18% | 49.13% | 48.50% |
| BioCryst Pharmaceuticals, Inc. (BCRX)vs › | $2.04B | N/A | -101.38% | -17.29% | 175.33% |
| Inspire Medical Systems, Inc. (INSP)vs › | $2.02B | 16.36% | 13.19% | 3.41% | -4.94% |
| Mineralys Therapeutics, Inc. (MLYS)vs › | $2.02B | -63.45% | -58.44% | -22.42% | 15.04% |
| Aurinia Pharmaceuticals Inc. (AUPH)vs › | $2.01B | 51.09% | 25.46% | 0.90% | -9.89% |
| AxoGen, Inc. (AXGN)vs › | $2.00B | -13.09% | -10.89% | -18.29% | -19.41% |
ROE
-42.1%
ROA
-38.4%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -42.07% |
| 2026-03-31 | -62.18% |
| 2025-12-31 | -49.09% |
| 2025-09-30 | -37.52% |
| 2025-06-30 | -30.46% |
| 2025-03-31 | -25.44% |
| 2024-12-31 | -21.13% |
| 2024-09-30 | -19.61% |
| 2024-06-30 | -18.46% |
| 2024-03-31 | -17.28% |
| 2023-12-31 | -32.95% |
| 2023-09-30 | -50.51% |
| 2023-06-30 | -40.76% |
| 2023-03-31 | -39.19% |
| 2022-12-31 | -34.43% |
| 2022-09-30 | -30.68% |
| 2022-06-30 | -27.30% |
| 2022-03-31 | -19.35% |
| 2021-12-31 | -16.81% |
| 2021-09-30 | -16.55% |
| 2021-06-30 | -36.23% |
| 2021-03-31 | -32.80% |
| 2020-12-31 | -28.55% |
| 2020-09-30 | -21.01% |
| 2020-06-30 | -19.09% |
| 2020-03-31 | -55.27% |
| 2019-12-31 | -54.11% |
| 2019-09-30 | -49.15% |
| 2019-06-30 | -41.65% |
| 2019-03-31 | -44.63% |
| 2018-12-31 | -121.86% |
| 2018-09-30 | -113.65% |
| 2018-06-30 | -128.66% |
| 2018-03-31 | -131.94% |
| 2017-12-31 | -39.36% |
| 2017-09-30 | -55.44% |
| 2017-06-30 | -53.89% |
| 2017-03-31 | -51.69% |
| 2016-12-31 | -48.42% |
| 2016-09-30 | -59.38% |
| 2016-06-30 | -55.94% |
| 2016-03-31 | -50.65% |
| 2015-12-31 | -43.85% |
| 2015-09-30 | -39.65% |
| 2015-06-30 | -35.40% |
| 2015-03-31 | -31.51% |
| 2014-12-31 | -55.79% |
| 2014-09-30 | -45.25% |
| 2014-06-30 | -38.96% |
| 2014-03-31 | -32.25% |
| 2013-12-31 | -25.50% |
| 2013-09-30 | -48.67% |
| 2013-06-30 | -38.50% |
| 2013-03-31 | -32.29% |
| 2012-12-31 | -61.73% |
| 2012-09-30 | -60.48% |
| 2012-06-30 | -54.78% |
| 2012-03-31 | -44.73% |
| 2011-12-31 | -65.19% |
| 2011-09-30 | -11.66% |
| 2011-06-30 | -7.31% |
| 2011-03-31 | -9.14% |
| 2010-12-31 | -3.37% |
| 2010-09-30 | -73.31% |
| 2010-06-30 | -60.37% |
| 2010-03-31 | -51.72% |
| 2009-12-31 | -49.52% |
| 2009-06-30 | -732.47% |
| 2009-03-31 | -280.52% |
| 2008-12-31 | -261.95% |
| 2008-09-30 | -190.04% |
| 2008-06-30 | -141.68% |
| 2008-03-31 | -121.42% |
| 2006-12-31 | -942.81% |
| 2006-09-30 | -235.62% |
| 2006-06-30 | -133.88% |
| 2006-03-31 | -89.06% |
| 2005-12-31 | -86.63% |
| 2005-09-30 | -72.16% |
| 2005-06-30 | -58.51% |
| 2005-03-31 | -48.01% |
| 2004-12-31 | -34.38% |
| 2004-09-30 | -32.19% |
| 2004-06-30 | -26.18% |
| 2004-03-31 | -22.71% |
| 2003-12-31 | -45.38% |
| 2003-09-30 | -38.02% |
| 2003-06-30 | -41.67% |
